New drug Dostarlimab cures all patients in trial 'first time in history
A small clinical trial discovered that every single rectal cancer patient who got an experimental treatment saw their disease vanish, in what looks to be a miracle and a "first in history". According to the New York Times, 18 patients took a medicine named Dostarlimab for six months in a limited clinical trial done by Memorial Sloan Kettering Cancer Center, and all of them saw their tumours shrink at the end. Experts stated that the malignancy is undetectable by physical examination, endoscopy, positron emission tomography or PET scans, or MRI scans. This shows that Dostarlimab has the potential to be a 'possible' cancer cure for one of the most lethal tumours.
For Further
Info:-https://bit.ly/3mpHiT4
Comments
Post a Comment